Flortaucipir

Telix Pharmaceuticals, in collaboration with Grand Pharmaceutical Group, has dosed the first patient in China for its Phase III ZIRCON-CP trial of TLX250-CDx, a PET imaging agent for clear cell renal cell carcinomas. The trial aims to support previous global Phase III ZIRCON trial results and demonstrate TLX250-CDx's efficacy in Chinese populations.

Siemens Healthineers received FDA clearance for syngo.PET Cortical Analysis software features: Centiloid scoring for standardized beta-amyloid plaque quantification and tau PET quantification for assessing tau protein tangles, aiding Alzheimer’s disease diagnosis and staging.

FDA clears Centiloid scoring and tau PET quantification in syngo.PET Cortical Analysis software (Siemens Healthineers), enabling beta-amyloid plaque assessment and tau protein tangle quantification for Alzheimer’s diagnosis and staging.

Siemens Healthineers receives CE Mark for syngo.PET Cortical Analysis software features: Centiloid scoring standardizes amyloid plaque quantification, and tau PET quantification assesses tau protein tangles, aiding Alzheimer’s diagnosis and staging.